Core Viewpoint - The medical device sector in China is experiencing a robust growth trajectory, with significant market activity and investment interest, particularly in the context of recent stock performance and market data. Group 1: Market Performance - On November 10, the Shanghai Composite Index saw a rebound, with strong performances in sectors such as food and beverage, beauty care, and pharmaceuticals [1] - The Medical Device Index ETF (159898) rose by 1.75%, with a net subscription of approximately 11 million units, equating to about 6.4 million yuan based on real-time net value [1] Group 2: Industry Growth - According to data from Zhongcheng Shuke, the overall market size of medical device bidding in China grew by 29.8% year-on-year in Q3 2025, indicating a stable growth trend despite a slight deceleration compared to previous quarters [3] - Medical device exports reached $15.224 billion in Q3 2025, marking a year-on-year increase of 4.53%, with medical consumables and equipment exports growing by 3.32% and 8.83%, respectively [3] Group 3: Investment Insights - Zhongtai Securities highlights that the domestic medical device industry is in a rapid development phase, with potential short-term negative impacts from medical insurance cost control and international conditions, but a long-term optimistic outlook driven by innovation and import substitution [3] - The Medical Device Index ETF (159898) tracks the CSI All-Share Medical Device Index, with a composition of 42.42% medical equipment, 33.77% medical consumables, and 23.81% in vitro diagnostics, making it a pure representation of the A-share medical device sector [3] - Over 80% of the constituents of the CSI All-Share Medical Device Index are distributed across the Sci-Tech Innovation Board and the Growth Enterprise Market, highlighting a strong focus on technology-driven growth [3]
资金悄然布局低位品种！医疗器械指数ETF(159898)盘中获640万净流入，板块拐点预期升温
Sou Hu Cai Jing·2025-11-10 06:43